Bausch + Lomb BLCO Surgical — Operating Income (Loss)

Other segment segments

Similar metrics at other companies

CRLSegment operating income — Operating Income (Loss)

$200.49M+55.5%

NOVTMedical Solutions — Segment Operating Income

$16.73M+19.2%

AHROutpatient Medical — Operating Income

$18.72M-8.7%

APGSpecialty Services — Operating Income (Loss)

$39M+34.5%

BDCOperating Income

$77.96M+7.3%

DHRLife Sciences — Operating Income (Loss)

$225M+11.9%

Questions, answered.

What is Bausch + Lomb's surgical — operating income (loss)?

Bausch + Lomb (BLCO) reported surgical — operating income (loss) of $9M in Q1 2026.

How has Bausch + Lomb's surgical — operating income (loss) changed year-over-year?

Bausch + Lomb's surgical — operating income (loss) increased by 228.6% year-over-year, from -$7M to $9M.

What is the long-term trend for Bausch + Lomb's surgical — operating income (loss)?

Over 4 years (2021 to 2025), Bausch + Lomb's surgical — operating income (loss) has grown at a -30.0% compound annual growth rate (CAGR), from $75M to $18M.

What does surgical — operating income (loss) mean?

Calculated as the surgical segment's total revenue minus its operating expenses, including cost of goods sold, R&D, and SG&A. This metric provides a clear view of the core profitability of the surgical business before interest and taxes. It is the primary benchmark for evaluating the operational success of the segment's business model.